A pilot study of peptide vaccines for VEGF receptor 1 and 2 in patients with recurrent/progressive high grade glioma.
Shibao S, Ueda R, Saito K, Kikuchi R, Nagashima H, Kojima A, Kagami H, Pareira ES, Sasaki H, Noji S, Kawakami Y, Yoshida K, Toda M.
Shibao S, et al. Among authors: kikuchi r.
Oncotarget. 2018 Apr 20;9(30):21569-21579. doi: 10.18632/oncotarget.25131. eCollection 2018 Apr 20.
Oncotarget. 2018.
PMID: 29765561
Free PMC article.